Retractable Technologies
RVP
$1.08
Share price
1.42%
Change (1 day)
-37.13%
Change (1 year)
Categories
P/S ratio for Retractable Technologies (RVP)
P/S ratio as of April 2024 (TTM): 0.7382
According to Retractable Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.738183. At the end of 2023 the company had a P/S ratio of 0.7622.
P/S ratio history for Retractable Technologies from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.7622 | 33.79% |
| 2022 | 0.5697 | -54.13% |
| 2021 | 1.24 | -72% |
| 2020 | 4.44 | 278.35% |
| 2019 | 1.17 | 100.75% |
| 2018 | 0.5841 | -9.29% |
| 2017 | 0.6440 | -30.35% |
| 2016 | 0.9246 | -69.2% |
| 2015 | 3.00 | -24.94% |
| 2014 | 4.00 | 47.04% |
| 2013 | 2.72 | 285.99% |
| 2012 | 0.7047 | -24.16% |
| 2011 | 0.9292 | -19.78% |
| 2010 | 1.16 | 15.57% |
| 2009 | 1.00 | 38.23% |
| 2008 | 0.7251 | -47.21% |
| 2007 | 1.37 | -49.1% |
| 2006 | 2.70 | -22.53% |
| 2005 | 3.48 | -29.77% |
| 2004 | 4.96 | -29.02% |
| 2003 | 6.99 | 83.84% |
| 2002 | 3.80 | -43.35% |
| 2001 | 6.71 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 3.43 | 365.26% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | 3.05 | 313.03% | 🇺🇸 USA |
 ICU Medical
ICUI | 1.02 | 38.83% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |
 Insulet PODD | 6.86 | 828.74% | 🇺🇸 USA |